Understanding breast tissue using advanced MRI techniques
Comprehensive Characterization of Breast Tissue Using Multi-modal MRI
This study is looking at a special type of MRI to learn more about breast tissue and improve how we diagnose and treat breast cancer, helping patients get a clearer picture of their breast health.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10778634 on NIH RePORTER |
What this research studies
This research investigates the use of advanced diffusion-weighted MRI (DWI) to better understand the properties of breast tissue, particularly in relation to breast cancer. By utilizing various models and measurements, the study aims to reveal hidden characteristics of breast tissue that traditional MRI methods may overlook. Patients may undergo MRI scans that assess tissue cellularity, microvascularity, and microstructural heterogeneity, providing a more comprehensive view of their breast health. This approach could enhance the accuracy of breast cancer diagnosis and treatment planning.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals undergoing evaluation for breast cancer or those with a family history of breast cancer.
Not a fit: Patients with non-breast-related conditions or those who have already been diagnosed and treated for breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic techniques for breast cancer, allowing for earlier detection and more personalized treatment options.
How similar studies have performed: Other research has shown promise in using advanced MRI techniques for cancer detection, indicating that this approach could yield significant insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Karaman, Muge M — University of Illinois at Chicago
- Study coordinator: Karaman, Muge M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.